Obermatt

Henry Schein

NSQ:HSIC · US8064071025
Health Care Providers & ServicesX-Large

360

41
EV / EBIT58
Price / Owner Earnings63
Owner Earnings Yield79
Dividend Yield1
Price/Sales59
EV / Gross Profit84
Price/Book45
Return on Capital56
Cash Return on Capital54
Return on Equity46
EBIT Margin39
Gross Profitability85
Cash Conversion38
Accruals35
Owner Earnings Margin52
Sales growth42
Profit Growth79
Long-Term EPS Growth55
Owner Earnings Growth46
Reinvestment26
Price momentum54
Debt load52
Refinancing91
Debt Payback38
Liquidity64
Analyst ratings28
Opinion Changes50
Price Target Upside26
Market mood35
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Henry Schein clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
TypePublic Company
ExchangeNASDAQGS
Founded1992
Employees7,682
ISINUS8064071025
Last UpdateApr 2, 2026
Themes
Health DiagnosticsSoftware DevelopmentDentistryOrthopaedicsVaccinesDentalHealth CareMedical Device

Description

Henry Schein, Inc. (Henry Schein) operates as a solutions company for health care professionals powered by a network of people and technology. The company provides health care products and services primarily to office-based dental and medical practi…

Analysis

Middle-of-the-road

Henry Schein, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is fair. You pay 16.5× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 4% yearly growth; analysts expect 11%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is stretched. The company scores 8/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
61
2023202420252026

All-time high

75

Oct 2025

All-time low

36

Jan 2025

Average rank

58

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
59
58
54
60
Price/Earnings
64
51
67
39
Price/Book
45
37
49
58
Dividend Yield
1
1
1
1
Value (overall)
42
37
41
54

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Henry Schein with its peers
Climb Global Solutions
NMQ:CLMB
99
CountryUSA
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Hims & Hers Health
NYQ:HIMS
3
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
AMN Healthcare
NYQ:AMN
92
CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Cross Country Healthcare
NSQ:CCRN
30
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
LifeStance Health
NSQ:LFST
80
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
CVS Health
NYQ:CVS
29
CountryUSA
IndustryHealth Care Providers & Services
SizeXX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →